Dendritic cell-based vaccine efficacy: aiming for hot spots
/in Dendritic Cells, International Publications /von 2015-03-03 / Front Immunol 2015;6:91Comparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-03-02 / Exp. Biol. Med. (Maywood) 2015 Oct;240(10):1310-8Matched-pair analysis of dendritic cell versus targeted-therapy in patients with metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2015-03-01 / Anticancer Res. 2015 Mar;35(3):1575-82Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2015-02-26 / Gynecol. Oncol. 2015 May;137(2):335-42Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2015-02-16 / Int. Immunopharmacol. 2015 Apr;25(2):450-6Antitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2015-02-11 / Cancer Res. 2015 Apr;75(7):1265-74A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment
/in Dendritic Cells, International Publications, Prostate Cancer /von 2015-01-29 / Oncol. Rep. 2015 Apr;33(4):1585-92Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2015-01-23 / Int. J. Oncol. 2015 Apr;46(4):1699-709Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma /von 2015-01-22 / Br. J. Haematol. 2015 May;169(3):356-67
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de